Literature DB >> 2621167

Mycinamicins, new macrolide antibiotics. XI. Isolation and structure elucidation of a key intermediate in the biosynthesis of the mycinamicins, mycinamicin VIII.

K Kinoshita1, Y Imura, S Takenaka, M Hayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2621167     DOI： 10.7164/antibiotics.42.1869

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  7 in total

1.  Functional analysis of MycCI and MycG, cytochrome P450 enzymes involved in biosynthesis of mycinamicin macrolide antibiotics.

Authors:  Yojiro Anzai; Shengying Li; Mani Raj Chaulagain; Kenji Kinoshita; Fumio Kato; John Montgomery; David H Sherman
Journal:  Chem Biol       Date:  2008-09-22

Review 2.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

3.  Substrate recognition by the multifunctional cytochrome P450 MycG in mycinamicin hydroxylation and epoxidation reactions.

Authors:  Shengying Li; Drew R Tietz; Florentine U Rutaganira; Petrea M Kells; Yojiro Anzai; Fumio Kato; Thomas C Pochapsky; David H Sherman; Larissa M Podust
Journal:  J Biol Chem       Date:  2012-09-05       Impact factor: 5.157

4.  A new mycinosyl rosamicin derivative produced by an engineered Micromonospora rosaria mutant with a cytochrome P450 gene disruption introducing the D-mycinose biosynthetic gene.

Authors:  Yohei Iizaka; Noriko Higashi; Wei Li; Atsushi Fukumoto; Yojiro Anzai; Fumio Kato
Journal:  J Ind Microbiol Biotechnol       Date:  2014-07-22       Impact factor: 3.346

5.  Production of a hybrid 16-membered macrolide antibiotic by genetic engineering of Micromonospora sp. TPMA0041.

Authors:  Ayami Sakai; Aki Mitsumori; Mika Furukawa; Kenji Kinoshita; Yojiro Anzai; Fumio Kato
Journal:  J Ind Microbiol Biotechnol       Date:  2012-07-29       Impact factor: 3.346

6.  Production of rosamicin derivatives in Micromonospora rosaria by introduction of D-mycinose biosynthetic gene with PhiC31-derived integration vector pSET152.

Authors:  Yojiro Anzai; Yohei Iizaka; Wei Li; Naoki Idemoto; Shu-ichi Tsukada; Kazuo Koike; Kenji Kinoshita; Fumio Kato
Journal:  J Ind Microbiol Biotechnol       Date:  2009-05-02       Impact factor: 3.346

7.  Biochemical and Structural Characterization of MycCI, a Versatile P450 Biocatalyst from the Mycinamicin Biosynthetic Pathway.

Authors:  Matthew D DeMars; Fang Sheng; Sung Ryeol Park; Andrew N Lowell; Larissa M Podust; David H Sherman
Journal:  ACS Chem Biol       Date:  2016-08-05       Impact factor: 5.100
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.